Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Reduced pathogenicity of phenotypically and genotypically characterized cidofovir (CDV)-resistant vaccinia virus (VV) — Graciela Andreï (2005) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Reduced pathogenicity of phenotypically and genotypically characterized cidofovir (CDV)-resistant vaccinia virus (VV)
Shared by
De Clercq Erik
KU Leuven
Reduced pathogenicity of phenotypically and genotypically characterized cidofovir (CDV)-resistant vaccinia virus (VV)
Article
2005
en
Authors
+2 more
GA
Graciela Andreï
PF
Pierre Fiten
De Clercq Erik
KU Leuven
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2004
Isolation of vaccinia virus (VV) mutants resistant to different acyclic nucleoside phosphonate analogues (ANPs)
Graciela Andreï
,
A. HOLY
,
Pierre Fiten
,
Ghislain Opdenakker
,
De Clercq Erik
,
Robert Snoeck
Article
2006
Cidofovir Resistance in Vaccinia Virus Is Linked to Diminished Virulencein Mice
Graciela Andreï
,
Don B. Gammon
,
Pierre Fiten
,
De Clercq Erik
,
Ghislain Opdenakker
,
Robert Snoeck
,
David H. Evans
Article
2006
Drug susceptibility profiles of recombinant vaccinia virus harboring mutation(s) conferring resistance to cidofovir
Graciela Andreï
,
Don B. Gammon
,
Pierre Fiten
,
Ghislain Opdenakker
,
De Clercq Erik
,
Robert Snoeck
,
David H. Evans
Article
2007
Mononuclear Cells as a Transfer Vehicle For Herpes Simplex Virus (HSV) or Vaccinia Virus (VV) Infection of Epithelial Cells Grown in 3D
Graciela Andreï
,
J VANDENOORD
,
De Clercq Erik
,
Robert Snoeck
Article
2004
Efficacy of Cidofovir in a Murine Model of Disseminated Progressive Vaccinia
Johan Neyts
,
Pieter Leyssen
,
Erik Verbeken
,
De Clercq Erik
Discussion(0)
No comments yet. Be the first to comment.